AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ARBUTHNOT BANKING GROUP PLC

Board/Management Information Jul 6, 2022

7492_rns_2022-07-06_002c1cbf-f2a4-4255-a249-47c97d28c92e.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 5572R

Arbuthnot Banking Group PLC

06 July 2022

6 July 2022

Arbuthnot Banking Group PLC

Change to Sole Corporate Broker

The Board of Arbuthnot Banking Group PLC ("Arbuthnot" or the "Group") announces that Shore Capital will now act as the Group's sole Corporate Broker. Grant Thornton UK LLP continues to act as Arbuthnot's Nominated Adviser and AQSE Exchange Corporate Adviser.

The directors of the Company accept responsibility for the contents of this announcement.

Enquiries:

Arbuthnot Banking Group                                                                                                           020 7012 2400

Sir Henry Angest, Chairman and Chief Executive

Andrew Salmon, Group Chief Operating Officer

James Cobb, Group Finance Director

Grant Thornton UK LLP (Nominated Adviser and

AQSE Exchange Corporate Adviser)                                                                                         020 7383 5100

Colin Aaronson

Samantha Harrison

George Grainger

Ciara Donnelly 

Shore Capital (Broker)                                                                                                                   020 7408 4090

Daniel Bush

Tom Knibbs

Maitland/AMO (Financial PR)                                                                                                    020 7379 5151

Sam Cartwright

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCUPUCGMUPPGPQ

Talk to a Data Expert

Have a question? We'll get back to you promptly.